High fives and sobs greet UnitedHealthcare’s reversal of denials for gene therapy

Author

Sophie

Publish date

Two young children will receive a novel drug to treat spinal muscular atrophy thanks to UnitedHealthcare’s reversal of denials for gene therapy: https://www.washingtonpost.com/business/economy/high-fives-and-sobs-greet-unitedhealthcares-reversal-of-denials-for-child-gene-therapy/2019/07/18/8ddeb3ae-a974-11e9-9214-246e594de5d5_story.html

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Privacy Policy. By closing this message, you are consenting to our use of cookies.